Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Camas Incorporated manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by 1 distinct examiner, STEPHENS, AMELIA CAROLE, who is the busiest examiner for the company with 1 pending office action. The prosecution activity is limited to 1 distinct art unit.
The presence of only 1 pending office action indicates a low volume of current prosecution activity. Because there is only 1 distinct examiner and 1 distinct art unit, the company's interactions with the USPTO are highly centralized. STEPHENS, AMELIA CAROLE is the only official currently overseeing the company's pending patent work.
The concentration of the workload under a single examiner suggests a streamlined prosecution process. Because there is only 1 busiest examiner pending action, the technical focus of the examination remains narrow. Practitioners working with STEPHENS, AMELIA CAROLE will find that this individual manages the entirety of the company's currently pending work. This structure allows for a very specific legal strategy tailored to the preferences of a single examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEPHENS, AMELIA CAROLE | 1 | 85.7% | +33.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18032491 | Methods of using passive immunity to decrease transmission of infectious diseases | STEPHENS, AMELIA CAROLE | 43d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18032491 | Methods of using passive immunity to decrease transmission of infectious diseases | STEPHENS, AMELIA CAROLE | 43d overdue |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18032491 | Methods of using passive immunity to decrease transmission of infectious diseases | STEPHENS, AMELIA CAROLE | 1645 | §102§112DP | Final Rejection | 43d overdue | Pending | Apr 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial